Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effect Noted in The Apo/Apo-1 Ratio Using Rosuvastatin and Atorvastatin in Patients With acUte Coronary Syndrome CENTAURUS Study

NCT00665834 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT00665834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00665834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effect Noted in The Apo/Apo-1 Ratio Using Rosuvastatin and Atorvastatin in Patients With acUte Coronary Syndrome CENTAURUS Study
Lead sponsor
Queen's University
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2006
Completion date
September 30, 2007
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, dyslipidemia